Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRay GroupSHSE:688301 -2.07%95 Interest Coverage is 9.36 as of Jun. 2026, which is 76% below its 10-year median of 38.67. GuruFocus rates SHSE:688301 with a GF Score™ of 95/100 and a GF Value™ of ¥109.99 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 461 Medical Devices & Instruments companies, iRay Group ranks worse than 59.87% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. iRay Group's
Operating Income
for the
three
months ended in Jun. 2026 was ¥323 Mil. iRay Group's Interest Expense for the
three
months ended in Jun. 2026 was ¥-35 Mil.
iRay Group's interest coverage for the quarter that ended in Jun. 2026 was 9.36.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for iRay Group's Interest Coverage or its related term are showing as below:
SHSE:688301'
s Interest Coverage Range Over the Past 10 Years
Min: 10.68 Med: 38.67 Max: No Debt
Current: 10.68
SHSE:688301's Interest Coverage is ranked worse than 59.87% of 461
companies
in the Medical Devices & Instruments industry
Industry Median: 16.91
vs SHSE:688301: 10.68
iRay Group (SHSE:688301) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
iRay Group Interest Coverage Related Terms
iRay Group Interest Coverage Historical Data
* Premium members only.
The historical data trend for iRay Group's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHSE:688301 vs ISRG, BDX, RMD: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, iRay Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRay Group Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRay Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where iRay Group's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRay Group (SHSE:688301) has a Interest Coverage of 9.36 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on iRay Group and its competitors. This is 76% below median its historical median of 38.67. Over the past decade, iRay Group's Interest Coverage has ranged from 10.68 to 10,000.00. According to the industry distribution chart, iRay Group ranks #276 out of 461 companies in the Medical Devices & Instruments industry, placing it in the top 59.9%.
Is iRay Group's Interest Coverage too high?
iRay Group's current Interest Coverage of 9.36 is 76% below median its 10-year median of 38.67. Over the past 10 years, this metric has ranged from a low of 10.68 to a high of 10,000.00. The Medical Devices & Instruments industry median Interest Coverage is 16.91. iRay Group's value of 9.36 is 44.6% below this industry median. Based on the distribution chart, iRay Group ranks #276 out of 461 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, iRay Group has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRay Group's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iRay Group ranks #276 out of 461 companies for Interest Coverage. This places iRay Group in the lower half of its industry. The industry median Interest Coverage is 16.91. iRay Group's value of 9.36 is 44.6% below this benchmark. Historically, iRay Group's own Interest Coverage has ranged from 10.68 to 10,000.00 over the past decade. While the company's 10-year median is 38.67 vs. the industry median of 16.91, iRay Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.91, based on 461 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRay Group's current Interest Coverage of 9.36 is 44.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on iRay Group and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRay Group's current Interest Coverage is 9.36, which is 76% below median its own 10-year median of 38.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRay Group stock overvalued right now?
Based on GuruFocus' analysis, iRay Group (SHSE:688301) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥109.99, compared to a current price of ¥88.54 — trading 19.5% below its estimated fair value. The current Interest Coverage is 9.36, which is 76% below median its 10-year median of 38.67 and 44.6% below the Medical Devices & Instruments industry median of 16.91. iRay Group's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For iRay Group (SHSE:688301), the current Interest Coverage is 9.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRay Group (SHSE:688301) Overvalued in 2026?
Based on GuruFocus' analysis, iRay Group stock appears to be undervalued.
The current stock price of ¥88.54 is trading 19.5% below its estimated GF Value™ of ¥109.99.
GuruFocus considers iRay Group to be Modestly Undervalued.
Key valuation signals for SHSE:688301:
Interest Coverage: 9.36 (76% below median its 10-year median of 38.67)
GF Value™: ¥109.99 vs. price of ¥88.54 (19.5% below fair value)
Industry Position: 44.6% below the Medical Devices & Instruments median (#276 of 461)
No single metric tells the full story. See the SHSE:688301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688301 has been successfully added to your 
